Colon cancer blood test offers new screening option
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths.
The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold standard for colon cancer screening. Besides spotting tumors, colonoscopies can prevent the disease by removing precancerous growths called polyps.
But some people avoid the exam because of the hassle of getting time off work or the day-ahead preparation that involves drinking a strong laxative to empty the bowels.
Related articles
Devout Christian doctor, 68, who punched dementia
An 'arrogant' doctor who punched a vulnerable patient for making a racist comment and spitting at hi2024-05-21Scamacca put PlayStation away and began scoring. Now game time may come as center forward for Italy
ROME (AP) — The message was clear from Italy coach Luciano Spalletti: Put your PlayStation away and2024-05-21- A-list celebrities such as Kate Moss, Sam Smith and Emily Ratajkowski attended a New York bonanza on2024-05-21
Scamacca put PlayStation away and began scoring. Now game time may come as center forward for Italy
ROME (AP) — The message was clear from Italy coach Luciano Spalletti: Put your PlayStation away and2024-05-21The government wants to buy their flood
HOUSTON (AP) — After the floodwaters earlier this month just about swallowed two of the six homes th2024-05-21Cambodia's Supreme Court upholds the 2
PHNOM PENH, Cambodia (AP) — Cambodia’s Supreme Court on Friday upheld the two-year prison sentence o2024-05-21
atest comment